Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation
Publication
, Conference
Horwitz, ME; Stiff, PJ; Chao, NJ; Rizzieri, D; Long, G; Sullivan, K; Gasparetto, C; Chute, J; Morris, A; McDonald, C; Wease, S; Snyder, D ...
Published in: Biology of Blood and Marrow Transplantation
February 2013
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2013
Volume
19
Issue
2
Start / End Page
S118 / S118
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Horwitz, M. E., Stiff, P. J., Chao, N. J., Rizzieri, D., Long, G., Sullivan, K., … Peled, T. (2013). Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation. In Biology of Blood and Marrow Transplantation (Vol. 19, pp. S118–S118). Elsevier BV. https://doi.org/10.1016/j.bbmt.2012.11.044
Horwitz, Mitchell E., Patrick J. Stiff, Nelson J. Chao, David Rizzieri, Gwynn Long, Keith Sullivan, Cristina Gasparetto, et al. “Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation.” In Biology of Blood and Marrow Transplantation, 19:S118–S118. Elsevier BV, 2013. https://doi.org/10.1016/j.bbmt.2012.11.044.
Horwitz ME, Stiff PJ, Chao NJ, Rizzieri D, Long G, Sullivan K, et al. Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2013. p. S118–S118.
Horwitz, Mitchell E., et al. “Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation.” Biology of Blood and Marrow Transplantation, vol. 19, no. 2, Elsevier BV, 2013, pp. S118–S118. Crossref, doi:10.1016/j.bbmt.2012.11.044.
Horwitz ME, Stiff PJ, Chao NJ, Rizzieri D, Long G, Sullivan K, Gasparetto C, Chute J, Morris A, McDonald C, Wease S, Snyder D, Galamidi-Cohen E, Shoham H, Landau E, Friend E, Kurtzberg J, Peled T. Nicord® Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation. Biology of Blood and Marrow Transplantation. Elsevier BV; 2013. p. S118–S118.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2013
Volume
19
Issue
2
Start / End Page
S118 / S118
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences